Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC

被引:45
|
作者
Risiglione, Pierpaolo [1 ]
Zinghirino, Federica [1 ]
Di Rosa, Maria Carmela [1 ]
Magri, Andrea [2 ,3 ]
Messina, Angela [2 ,3 ]
机构
[1] Univ Catania, Dept Biomed & Biotechnol Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[2] Univ Catania, Dept Biol Geol & Environm Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[3] WeMitoBiotech SRL, C So Italia 172, I-95125 Catania, Italy
关键词
Alpha-Synuclein; mitochondria; VDAC; Parkinson's disease; mitochondrial dysfunction; DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; BCL-2 FAMILY PROTEINS; COMPLEX-I DEFICIENCY; OXIDATIVE STRESS; HEXOKINASE-I; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; SUPEROXIDE-PRODUCTION; OLIGOMERS INTERACT;
D O I
10.3390/biom11050718
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-Synuclein (alpha Syn) is a protein whose function is still debated, as well as its role in modulation of mitochondrial function in both physiological and pathological conditions. Mitochondrial porins or Voltage-Dependent Anion Channel (VDAC) proteins are the main gates for ADP/ATP and various substrates towards the organelle. Furthermore, they act as a mitochondrial hub for many cytosolic proteins, including alpha Syn. This review analyzes the main aspects of alpha Syn-mitochondria interaction, focusing on the role of VDAC and its emerging involvement in the pathological processes.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson Disease
    Dolgacheva, L. P.
    Fedotova, E. I.
    Abramov, A. Y.
    Berezhnov, A. V.
    BIOLOGICHESKIE MEMBRANY, 2017, 34 (05): : 4 - 14
  • [2] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
    Dolgacheva L.P.
    Fedotova E.I.
    Abramov A.Y.
    Berezhnov A.V.
    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2018, 12 (1) : 10 - 19
  • [3] The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease
    Li, Hong-Yan
    Liu, De-Shui
    Zhang, Ying-Bo
    Rong, Hua
    Zhang, Xiao-Jie
    BIOPHYSICAL CHEMISTRY, 2023, 303
  • [4] Mitochondrial Dysfunction in Skin Fibroblasts from a Parkinson's Disease Patient with an alpha-Synuclein Triplication
    Mak, Sally K.
    Tewari, Deepika
    Tetrud, James W.
    Langston, J. William
    Schuele, Birgitt
    JOURNAL OF PARKINSONS DISEASE, 2011, 1 (02) : 175 - 183
  • [5] Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease
    Feng, Si-Tong
    Wang, Zhen-Zhen
    Yuan, Yu-He
    Sun, Hong-Mei
    Chen, Nai-Hong
    Zhang, Yi
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2021, 53 (09) : 2946 - 2959
  • [6] Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson's Disease
    Shen, Lydia
    Dettmer, Ulf
    BIOMOLECULES, 2024, 14 (12)
  • [7] Neurotoxicity by Hypoxia an Intermediate Between Alpha-synuclein and Mitochondrial Dysfunction in Parkinson's Disease
    Chand, Jagdish
    Fanai, Hannah Lalengzuali
    Antony, A. S.
    Subramanian, Gomathy
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2024, 15 (03) : 253 - 263
  • [8] α-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease
    Mullin, Stephen
    Schapira, Anthony
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 587 - 597
  • [9] Alpha-synuclein, lipids and Parkinson's disease
    Ruiperez, Violeta
    Darios, Frederic
    Davletov, Bazbek
    PROGRESS IN LIPID RESEARCH, 2010, 49 (04) : 420 - 428
  • [10] Parkinson's Disease, Cortical Dysfunction, and Alpha-Synuclein
    Caviness, John N.
    Lue, Lih-Fen
    Beach, Thomas G.
    Hentz, Joseph G.
    Adler, Charles H.
    Sue, Lucia
    Sadeghi, Ramin
    Driver-Dunckley, Erika
    Evidente, Virgilio G.
    Sabbagh, Marwan N.
    Shill, Holly A.
    Walker, Douglas G.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1436 - 1442